Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Games to Overcome Late Life Depression
Games to Overcome Late Life Depression
Status: Enrolling
Updated:  12/31/1969
University of Washington Department of Psychiatry and Behavioral Sciences
mi
from
Seattle, WA
Games to Overcome Late Life Depression
Games to Overcome Late Life Depression
Status: Enrolling
Updated: 12/31/1969
University of Washington Department of Psychiatry and Behavioral Sciences
mi
from
Seattle, WA
Click here to add this to my saved trials
Bupropion for Depression in ESRD Patients on Hemodialysis
Bupropion for Depression in ESRD Patients on Hemodialysis
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Bupropion for Depression in ESRD Patients on Hemodialysis
Bupropion for Depression in ESRD Patients on Hemodialysis
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Providence VA Medical Center
mi
from
Providence, RI
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Providence VA Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Birmingham, AL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Birmingham, AL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Beverly Hills, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Carson, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Carson, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Glendale, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Los Alamitos, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Los Angeles, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
National City, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
National City, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Pico Rivera, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Redlands, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Redlands, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Gabriel, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Gabriel, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Sherman Oaks, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Temecula, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Torrance, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Upland, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Upland, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Colorado Springs, CO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Denver, CO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hartford, CT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hartford, CT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Norwich, CT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Norwich, CT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Bradenton, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Coral Springs, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Coral Springs, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Fort Myers, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Gainesville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hallandale Beach, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hialeah, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Jacksonville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Jacksonville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Melbourne, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orlando, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
West Palm Beach, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Winter Haven, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes, Investigational Site
mi
from
Alpharetta, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes, Investigational Site
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Smyrna, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Smyrna, GA
Click here to add this to my saved trials